Skip to main content

Latigo Biotherapeutics, Inc.

corporate_fare Company Profile

Latigo Biotherapeutics, Inc.

LTGO·NASDAQ·Life Sciences·CIK 0002056611

Latigo Biotherapeutics, Inc. develops non-opioid pain medicines that aim to block pain transmission without the risk of addiction. The company's product pipeline includes LTG-001, an oral NaV1.8 inhibitor intended to offer fast-acting, opioid-sparing relief for acute pain. Another candidate, LTG-321, is a NaV1.8 inhibitor being developed for chronic musculoskeletal pain, with an initial focus on osteoarthritis. Additionally, LTG-418 is a NaV1.8 inhibitor designed for both acute and chronic pain treatment. Latigo Biotherapeutics, Inc. was incorporated in 2018 and is headquartered in Thousand Oaks, California. The company was previously known as WVB-Desmond, Inc. and adopted the name Latigo Biotherapeutics, Inc. in March 2019.

Latigo Biotherapeutics, Inc. (NASDAQ:LTGO) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 8 items for LTGO at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-05, rated 8/10. Across its 8 most recent items scored 7 or higher, the top rating is 8/10, with 5 rated 8 or above. Recent SEC coverage for LTGO spans 10-Q, 8-K, SCHEDULE 13D, 4.

Recent high-impact activity:

  • Latigo Posts $69.7M Nine-Month Loss; Material Weakness Persists in First Post-IPO 10-Q
  • Latigo Swaps CEO Two Months After IPO; Todd Smith Takes Over From Nima Farzan
  • Latigo 10-Q Reveals Material Weakness in Internal Controls Alongside Q2 Loss and IPO Details
  • Latigo Biotherapeutics Posts $27.59 Q2 Loss Per Share
  • Latigo Reports Q2 Loss of $25.8M, NEJM Publication, and Cash Runway into 2029

Short Interest & Short Volume

5.43 days to cover

FINRA reported short interest of 941,434 shares in LTGO as of the October 30, 2026 settlement, a 19.8% increase from the prior period — about 5.4 days to cover at its recent average daily volume. On November 20, 2026, 70.1% of LTGO volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)941,434 shares as of October 30, 2026
Change vs prior period▲ 19.8%
Days to cover5.43 at avg daily volume of 173,413
Daily short volume (FINRA facilities)70.1% of 79,328 shares on November 20, 2026
5-day average short volume59.1%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with L →
$13
52-week range · as of 2026-11-05 $13 – $25.93
Market cap
$861.89M
Volume
267.2K (1.0× avg)
3-mo avg 274.1K
Live data · 2026-11-22 05:10 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed LTGO - Latest Insights

LTGO
Nov 05, 2026, 7:23 AM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $14.16
Real-time Price: $13.00 info
Change: -$1.16 (-8%) info
Market Cap: $861.892M info
LTGO
Nov 05, 2026, 7:05 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $14.16
Real-time Price: $13.00 info
Change: -$1.16 (-8%) info
Market Cap: $861.892M info
LTGO
Sep 03, 2026, 4:32 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $22.48
Real-time Price: $13.00 info
Change: -$9.48 (-42%) info
Market Cap: $861.892M info
LTGO
Sep 03, 2026, 4:19 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $22.48
Real-time Price: $13.00 info
Change: -$9.48 (-42%) info
Market Cap: $861.892M info
LTGO
Sep 03, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $22.48
Real-time Price: $13.00 info
Change: -$9.48 (-42%) info
Market Cap: $861.892M info
LTGO
Aug 17, 2026, 7:06 PM EDT
Filing Type: SCHEDULE 13D
Importance Score:
7
Price at Filing: $19.30
Real-time Price: $13.00 info
Change: -$6.30 (-33%) info
Market Cap: $861.892M info
LTGO
Aug 10, 2026, 8:00 PM EDT
Filing Type: 4
Importance Score:
8
Price at Filing: $18.56
Real-time Price: $13.00 info
Change: -$5.56 (-30%) info
Market Cap: $861.892M info
LTGO
Aug 10, 2026, 4:02 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $18.56
Real-time Price: $13.00 info
Change: -$5.56 (-30%) info
Market Cap: $861.892M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets